WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Significant Increase in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 155,338 shares, an increase of 1,225.0% from the May 14th total of 11,724 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 479,488 shares, the short-interest ratio is presently 0.3 days.

WuXi Biologics (Cayman) Trading Down 2.3%

Shares of WuXi Biologics (Cayman) stock traded down $0.18 on Tuesday, hitting $7.60. 87,599 shares of the company were exchanged, compared to its average volume of 75,365. The company has a 50-day moving average price of $8.64 and a 200 day moving average price of $8.95. WuXi Biologics has a 1-year low of $6.02 and a 1-year high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.